Sharma East India Hospitals & Medical Research Ltd (524548)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Sharma East's revenue was ₹10.8 Cr (+13.7% year on year, +44.1% on the previous quarter), and net profit ₹0.3 Cr (-18.7% year on year); the operating margin was 8.0%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹10.8 | +13.7% | +44.1% |
| Operating profit | ₹0.9 | -6.6% | -15.0% |
| Net profit | ₹0.3 | -18.7% | -39.5% |
| EPS (₹) | 0.79 | — | — |
| Operating margin | 8.0% | — | — |
📢 Recent Corporate Announcements
Sharma East India Hospitals & Medical Research Ltd has approved its unaudited financial results for the quarter ended June 30, 2026. The statutory auditors, Gopal Sharma & Co., issued a limited review report with no material qualifications or misstatements. While the specific P&L figures for the current quarter were not detailed in the provided extract, the company enters this period with a TTM revenue of Rs 36 Cr and a PAT of Rs 1 Cr. Investors should monitor if the company recovers from the sequential revenue dip seen in March 2026 (Rs 7.47 Cr) compared to previous quarters.
- Board approval of unaudited standalone financial results for the quarter ended June 30, 2026.
- Limited Review Report issued by Gopal Sharma & Co. on August 12, 2026, with a clean opinion.
- Company reported a TTM revenue of Rs 36 Cr as of the previous fiscal year end.
- Promoter holding remains stable at 53.63% as per the latest available context.
- The company maintains a moderate Debt-to-Equity ratio of 0.53 based on a net worth of Rs 14 Cr.
The Board of Directors of Sharma East India Hospitals approved the standalone un-audited financial results for the quarter ended June 30, 2026, in a meeting held on August 12, 2026. The statutory auditors, Gopal Sharma & Co., provided a limited review report with no qualifications or material misstatements noted. This follows a trailing twelve-month (TTM) revenue of Rs 36 Cr and a PAT of Rs 1 Cr. Investors should monitor the detailed P&L to see if the company maintains its 10.1% operating margin.
- Board meeting held on August 12, 2026, concluded at 6:45 PM IST.
- Approval of Ind-AS compliant standalone results for the quarter ended June 30, 2026.
- Limited Review Report issued by Gopal Sharma & Co. with a clean opinion.
- Company operates with a TTM revenue base of Rs 36 Cr and a net worth of Rs 14 Cr.
- Promoter holding remains stable at 53.63% as per latest available data.
Sharma East India Hospitals & Medical Research Ltd has scheduled a board meeting on August 12, 2026, to approve its standalone un-audited financial results for the quarter ended June 30, 2026. This is a routine regulatory filing as per SEBI LODR regulations. The company currently operates with a TTM revenue of Rs 36 Cr and a thin net profit margin, with FY26 PAT standing at Rs 1.24 Cr. The trading window for insiders has been closed since July 1, 2026, and will remain so until 48 hours after the results are declared.
- Board meeting date set for August 12, 2026, to review Q1 performance.
- Financial results to be IND-AS compliant for the quarter ended June 30, 2026.
- Trading window closed from July 1, 2026, until 48 hours post-result declaration.
- Company reported a TTM revenue of Rs 36 Cr against a net worth of Rs 14 Cr.
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
